KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for West Pharmaceutical Services (WST) over the last 11 years, with Q3 2025 value amounting to -$200000.0.

  • West Pharmaceutical Services' Other Non Operating Income rose 7142.86% to -$200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$900000.0, marking a year-over-year increase of 4375.0%. This contributed to the annual value of -$1.0 million for FY2024, which is 13333.33% down from last year.
  • West Pharmaceutical Services' Other Non Operating Income amounted to -$200000.0 in Q3 2025, which was up 7142.86% from -$200000.0 recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Other Non Operating Income registered a high of $3.8 million during Q3 2023, and its lowest value of -$49.3 million during Q3 2022.
  • For the 5-year period, West Pharmaceutical Services' Other Non Operating Income averaged around -$3.1 million, with its median value being -$200000.0 (2025).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 60000.0% in 2021, then tumbled by 458181.82% in 2022.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Other Non Operating Income stood at $200000.0 in 2021, then plummeted by 1200.0% to -$2.2 million in 2022, then surged by 59.09% to -$900000.0 in 2023, then skyrocketed by 66.67% to -$300000.0 in 2024, then soared by 33.33% to -$200000.0 in 2025.
  • Its last three reported values are -$200000.0 in Q3 2025, -$200000.0 for Q2 2025, and -$200000.0 during Q1 2025.